The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review
Open accessAbstract
Frontotemporal dementia (FTD) is the second most common young-onset dementia and is clinically characterised by progressive behavioural change, executive dysfunction and language difficulties. Three clinical syndromes, behavioural variant FTD, semantic dementia and progressive non-fluent aphasia, form part of a clinicopathological spectrum named frontotemporal lobar degeneration (FTLD). The classical neuropsychological phenotype of FTD has been enriched by tests exploring Theory of Mind, social cognition and emotional processing. Imaging studies have detailed the patterns of atrophy associated with different clinical and pathological subtypes. These patterns offer some diagnostic utility, while measures of progression of atrophy may be of use in future trials. 30-50% of FTD is familial, and mutations in two genes, microtubule associated protein tau and Progranulin (GRN), account for about half of these cases. Rare defects in VCP, CHMP2B, TARDP and FUS genes have been found in a small number of families. Linkage to chromosome 9p13.2-21.3 has been established in familial FTD with motor neuron disease, although the causative gene is yet to be identified. Recent developments in the immunohistochemistry of FTLD, and also in amyotrophic lateral sclerosis (ALS), have led to a new pathological nomenclature. The two major groups are those with tau-positive inclusions (FTLD-tau) and those with ubiquitin-positive and TAR DNA-binding protein of 43 kDa (TDP-43) positive inclusions (FTLD-TDP). Recently, a new protein involved in familial ALS, fused in sarcoma (FUS), has been found in FTLD patients with ubiquitin-positive and TDP-43-negative inclusions. In this review, the authors discuss recent clinical, neuropsychological, imaging, genetic and pathological developments that have changed our understanding of FTD, its classification and criteria. The potential to establish an early diagnosis, predict underlying pathology during life and quantify disease progression will all be required for disease-specific therapeutic trials in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These brain regions have been previously shown to be susceptible to age-related neurodegenerative diseases.”
From Molecular and spatial signatures of mouse brain aging at single-cell resolution (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, there are several different pathological proteins and aggregation morphologies in FTD, with generally weak correlations between clinical syndrome and the type of pathological protein (Seelaar et al., 2011)”
From Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum (2020) · cites this paper as Seelaar et al., 2011
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, there are several different pathological proteins and aggregation morphologies in FTD, with generally weak correlations between clinical syndrome and the type of pathological protein (Seelaar et al., 2011)”
From Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum (2020) · cites this paper as Seelaar et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C. A., Rogelj, B., Hortobágyi, T., Vos, K. J. D., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B. N., Ruddy, D., Wright, P. D., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,625
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J. M., Kasarskis, E. J., Munsat, T. L., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,624
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Cognition and anatomy in three variants of primary progressive aphasia
Gorno‐Tempini, M. L., Dronkers, N. F., Rankin, K. P., Ogar, J. M., Phengrasamy, L., Rosen, H. J., Johnson, J. K., Weiner, M. W., & Miller, B. L. (2004) · Annals of Neurology · doi:10.1002/ana.10825 · Cited by 1,657
Research works printed but not linked: 2
- Pick A. U ¨ber die Beziehungen der senilen Hirnatropie zur Aphasie. Pragen Medizinischen Wochenschrift 1892;17:165e7.
- Alzheimer A. U ¨ber eigenartige Krankheitsfa ¨lle des spa ¨teren Alters. Zbl Ges Neurol Psych 1911;4:356e85.
Cited by
Sorted by citations
Qualitative Assessment of Verbal Fluency Performance in Frontotemporal Dementia
van den Berg, E., Jiskoot, L. C., Grosveld, M. J. H., Swieten, J. C. V., & Papma, J. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477538 · Cited by 2,065
Considering sex and gender in Alzheimer disease and other dementias
Podcasy, J., & Epperson, C. N. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.4/cepperson · Cited by 727
Rohrer, J. D., Nicholas, J. M., Cash, D. M., van Swieten, J., Dopper, E., Jiskoot, L., van Minkelen, R., Rombouts, S. A., Cardoso, M. J., Clegg, S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70324-2 · Cited by 538
Self-citationTau imaging: early progress and future directions
Villemagne, V. L., Fodero-Tavoletti, M. T., Masters, C. L., & Rowe, C. C. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70252-2 · Cited by 501
Enhanced Protein Degradation by Branched Ubiquitin Chains
Meyer, H., & Rapé, M. (2014) · Cell · doi:10.1016/j.cell.2014.03.037 · Cited by 493
Mahoney, C., Beck, J. A., Rohrer, J. D., Lashley, T., Mok, K. Y., Shakespeare, T. J., Yeatman, T., Warrington, E. K., Schott, J. M., Fox, N. C., et al. (2012) · Brain · doi:10.1093/brain/awr361 · Cited by 452
Self-citationSerum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
Rohrer, J. D., Woollacott, I., Dick, K. M., Brotherhood, E., Gordón, E., Fellows, A. D., Toombs, J., Druyeh, R., Cardoso, M. J., Sebastien Ourselin, A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003154 · Cited by 450
Self-citationMolecular and spatial signatures of mouse brain aging at single-cell resolution
Allen, W. E., Blosser, T. R., Sullivan, Z. A., Dulac, C., & Zhuang, X. (2023) · Cell · doi:10.1016/j.cell.2022.12.010 · Cited by 423
“These brain regions have been previously shown to be susceptible to age-related neurodegenerative diseases.(33,34) We sequenced 50,000 nuclei from two female animals at each age and performed unsupervised clustering analysis of the 80,000 cells that passed quality control (Figures S1A–S1F).”
BackgroundClinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration
Rohrer, J. D., Lashley, T., Schott, J. M., Warren, J. D., Mead, S., Isaacs, A. M., Beck, J. A., Hardy, J., de Silva, R., Warrington, E. K., et al. (2011) · Brain · doi:10.1093/brain/awr198 · Cited by 370
Self-citationMotor Neuron dysfunction in frontotemporal dementia
Burrell, J. R., Kiernan, M. C., Vucic, S., & Hodges, J. R. (2011) · Brain · doi:10.1093/brain/awr195 · Cited by 364
Loy, C. T., Schofield, P. R., Turner, A. M., & Kwok, J. B. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60630-3 · Cited by 342
Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD)
Brettschneider, J., Tredici, K. D., Irwin, D. J., Grossman, M., Robinson, J. L., Toledo, J. B., Fang, L., Deerlin, V. M. V., Ludolph, A. C., Lee, V. M. ‐., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1238-y · Cited by 328
The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions
Simón‐Sánchez, J., Dopper, E. G. P., Cohn‐Hokke, P. E., Hukema, R. K., Nicolaou, N., Seelaar, H., de Graaf, J. R. A., de Koning, I., van Schoor, N. M., Deeg, D. J. H., et al. (2012) · Brain · doi:10.1093/brain/awr353 · Cited by 275
Self-citationNeurofilament light chain: a biomarker for genetic frontotemporal dementia
Meeter, L. H., Dopper, E. G., Jiskoot, L. C., Sanchez‐Valle, R., Graff, C., Benussi, L., Ghidoni, R., Pijnenburg, Y. A., Borroni, B., Galimberti, D., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.325 · Cited by 263
Self-citationPoletti, M., Enrici, I., & Adenzato, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.004 · Cited by 278
Hiscox, L. V., Johnson, C. L., Barnhill, E., McGarry, M., Huston, J., van Beek, E. J. R., Starr, J. M., & Roberts, N. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/24/r401 · Cited by 244
Imaging and fluid biomarkers in frontotemporal dementia
Meeter, L. H., Kaat, L. D., Rohrer, J. D., & van Swieten, J. C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.75 · Cited by 210
Self-citationPhenotypic signatures of genetic frontotemporal dementia
Rohrer, J. D., & Warren, J. D. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834cd442 · Cited by 217
Self-citationNeurotransmitter deficits from frontotemporal lobar degeneration
Murley, A. G., & Rowe, J. B. (2017) · Brain · doi:10.1093/brain/awx327 · Cited by 211
How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia
van Blitterswijk, M., DeJesus‐Hernandez, M., & Rademakers, R. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a3efb · Cited by 211
Götzl, J. K., Mori, K., Daμμe, M., Fellerer, K., Tahirović, S., Kleinberger, G., Janssens, J., van der Zee, J., Lang, C. M., Kremmer, E., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1262-6 · Cited by 196
Bora, E., Walterfang, M., & Velakoulis, D. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309445 · Cited by 204
Choi, J., & Twamley, E. W. (2013) · Neuropsychology Review · doi:10.1007/s11065-013-9227-4 · Cited by 204
Gascon, E., Lynch, K., Ruan, H., Almeida, S., Verheyden, J. M., Seeley, W. W., Dickson, D. W., Petrucelli, L., Sun, D., Jiao, J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3717 · Cited by 183
Sander, K., Lashley, T., Gami, P., Gendron, T., Lythgoe, M. F., Rohrer, J. D., Schott, J. M., Revesz, T., Fox, N. C., & Årstad, E. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.01.003 · Cited by 187
Self-citationDepressive symptoms in neurodegenerative diseases
Baquero, M. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i8.682 · Cited by 187
Heterozygous TREM2 mutations in frontotemporal dementia
Borroni, B., Ferrari, F., Galimberti, D., Nacmias, B., Barone, C., Bagnoli, S., Fenoglio, C., Piaceri, I., Archetti, S., Bonvicini, C., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.017 · Cited by 173
Axonal transport defects and neurodegeneration: Molecular mechanisms and therapeutic implications
Guo, W., Dittlau, K. S., & Bosch, L. V. D. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.07.010 · Cited by 185
TREM2 in CNS homeostasis and neurodegenerative disease
Painter, M. M., Atagi, Y., Liu, C.-C., Rademakers, R., Xu, H., Fryer, J. D., & Bu, G. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0040-9 · Cited by 169
Progranulin in neurodegenerative disease
Petkau, T. L., & Leavitt, B. R. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.04.003 · Cited by 174
Linking pesticide exposure and dementia: What is the evidence?
Zaganas, I. V., Kapetanaki, S., Mastorodemos, V., Kanavouras, K., Colosio, C., Wilks, M. F., & Tsatsakis, A. M. (2013) · Toxicology · doi:10.1016/j.tox.2013.02.002 · Cited by 168
Biomarkers in dementia: clinical utility and new directions
Ahmed, R. M., Paterson, R. W., Warren, J. D., Zetterberg, H., O'Brien, J. T., Fox, N. C., Halliday, G. M., & Schott, J. M. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307662 · Cited by 159
Self-citationGenetics of Frontotemporal Dementia
Olszewska, D. A., Lonergan, R., Fallon, E., & Lynch, T. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0707-9 · Cited by 170
The clinical spectrum of sporadic and familial forms of frontotemporal dementia
Woollacott, I., & Rohrer, J. D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13654 · Cited by 163
Self-citationNeuroimaging Biomarkers of Neurodegenerative Diseases and Dementia
Risacher, S. L., & Saykin, A. J. (2013) · Seminars in Neurology · doi:10.1055/s-0033-1359312 · Cited by 155
Valdez, C., Wong, Y. C., Schwake, M., Bu, G., Wszołek, Z. K., & Krainc, D. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx364 · Cited by 148
Gallagher, M. D., Suh, E. R., Grossman, M., Elman, L. B., McCluskey, L. F., Swieten, J. C. V., Al‐Sarraj, S., Neumann, M., Gelpí, E., Ghetti, B. F., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1239-x · Cited by 148
Self-citationAbnormalities of connected speech in semantic dementia vs Alzheimer's disease
Sajjadi, S. A., Patterson, K., Tomek, M., & Nestor, P. J. (2012) · Aphasiology · doi:10.1080/02687038.2012.654933 · Cited by 142
Trajectories of cognitive decline in different types of dementia
Smits, L. L., van Harten, A. C., Pijnenburg, Y. A. L., Koedam, E. L. G. E., Bouwman, F. H., Sistermans, N., Reuling, I. E. W., Prins, N. D., Lemstra, A. W., Scheltens, P., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291714002153 · Cited by 134
Self-citationThe basis of clinicopathological heterogeneity in TDP-43 proteinopathy
Kawakami, I., Arai, T., & Hasegawa, M. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02077-x · Cited by 130
Frontotemporal Lobar Degeneration: Epidemiology, Pathology, Diagnosis and Management
Seltman, R. E., & Matthews, B. R. (2012) · CNS Drugs · doi:10.2165/11640070-000000000-00000 · Cited by 132
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
Valera, E., & Masliah, E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.013 · Cited by 132
The chromosome 9 ALS and FTD locus is probably derived from a single founder
Mok, K., Traynor, B. J., Schymick, J., Tienari, P. J., Laaksovirta, H., Peuralinna, T., Myllykangas, L., Chiò, A., Shatunov, A., Boeve, B. F., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.005 · Cited by 131
Lattante, S., Ciura, S., Rouleau, G. A., & Kabashi, E. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.03.005 · Cited by 138
Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum
Bevan-Jones, W. R., Cope, T. E., Jones, P. S., Kaalund, S. S., Passamonti, L., Allinson, K., Green, O., Hong, Y. T., Fryer, T. D., Arnold, R., et al. (2020) · Brain · doi:10.1093/brain/awaa033 · Cited by 124
Stamelou, M., Quinn, N. P., & Bhatia, K. P. (2013) · Movement Disorders · doi:10.1002/mds.25509 · Cited by 122
Profiles of white matter tract pathology in frontotemporal dementia
Mahoney, C. J., Ridgway, G. R., Malone, I. B., Downey, L. E., Beck, J., Kinnunen, K. M., Schmitz, N., Golden, H. L., Rohrer, J. D., Schott, J. M., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22468 · Cited by 124
Self-citationPhenotypic Heterogeneity of Monogenic Frontotemporal Dementia
Benussi, A., Padovani, A., & Borroni, B. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00171 · Cited by 129
Fluid biomarkers in frontotemporal dementia: past, present and future
Swift, I. J., Sogorb-Esteve, A., Heller, C., Synofzik, M., Otto, M., Graff, C., Galimberti, D., Todd, E., Heslegrave, A. J., van der Ende, E. L., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323520 · Cited by 122
Self-citationWhite Matter Integrity Disruptions Associated With Cognitive Impairments in Type 2 Diabetic Patients
Zhang, J., Wang, Y., Wang, J., Zhou, X., Shu, N., Wang, Y., & Zhang, Z. (2014) · Diabetes · doi:10.2337/db14-0342 · Cited by 121
C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts
Dobson‐Stone, C., Hallupp, M., Bartley, L., Shepherd, C. E., Halliday, G. M., Schofield, P. R., Hodges, J. R., & Kwok, J. B. (2012) · Neurology · doi:10.1212/wnl.0b013e3182684634 · Cited by 119
Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes
Ishigaki, S., Fujioka, Y., Okada, Y., Riku, Y., Udagawa, T., Honda, D., Yokoi, S., Endo, K., Ikenaka, K., Takagi, S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.013 · Cited by 118
Snowden, J. S., Adams, J., Harris, J., Thompson, J. C., Rollinson, S. J., Richardson, A. M. T., Jones, M. S., Neary, D., Mann, D. M. A., & Pickering-Brown, S. M. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1074700 · Cited by 132
A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression
Gallagher, M. D., Posavi, M., Huang, P., Unger, T. L., Berlyand, Y., Gruenewald, A. L., Chesi, A., Manduchi, E., Wells, A. D., Grant, S. F. A., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.09.004 · Cited by 112
Modeling human neurodegenerative diseases in transgenic systems
Sosa, M. A. G., Gasperi, R. D., & Elder, G. A. (2011) · Human Genetics · doi:10.1007/s00439-011-1119-1 · Cited by 114
Neuroimaging in frontotemporal dementia
Rohrer, J. D., & Rosen, H. J. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.778822 · Cited by 114
Self-citationA critical review of chronic traumatic encephalopathy
Iverson, G. L., Gardner, A. J., McCrory, P., Zafonte, R., & Castellani, R. J. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.008 · Cited by 103
Teunissen, C. E., Elias, N., Koel‐Simmelink, M. J. A., Durieux‐Lu, S., Malekzadeh, A., Pham, T. V., Piersma, S. R., Beccari, T., Meeter, L. H. H., Dopper, E. G. P., et al. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.12.004 · Cited by 103
Self-citationJohnen, A., & Bertoux, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00594 · Cited by 112
Kim, J. P., Kim, J., Park, Y. H., Park, S. B., Lee, J. S., Yoo, S., Kim, E.-J., Kim, H. J., Na, D. L., Brown, J. A., et al. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.101811 · Cited by 100
Early-onset dementias: diagnostic and etiological considerations
Masellis, M., Sherborn, K., Rosa‐Neto, P., Sadovnick, A. D., Hsiung, G. R., Black, S. E., Prasad, S., Williams, M., & Gauthier, S. G. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt197 · Cited by 102
Yokoi, S., Udagawa, T., Fujioka, Y., Honda, D., Okado, H., Watanabe, H., Katsuno, M., Ishigaki, S., & Sobue, G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.100 · Cited by 104
Montreal Cognitive Assessment (MoCA): Validation study for Frontotemporal Dementia
Freitas, S., Simões, M. R., Alves, L., Duro, D., & Santana, I. J. (2012) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988712455235 · Cited by 111
Panman, J. L., Jiskoot, L. C., Bouts, M. J. R. J., Meeter, L. H. H., van der Ende, E. L., Poos, J. M., Feis, R. A., Kievit, A. J. A., van Minkelen, R., Dopper, E. G. P., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.12.017 · Cited by 104
Lehmann, M., Koedam, E., Barnes, J., Bartlett, J. W., Ryan, N. S., Pijnenburg, Y. A. L., Barkhof, F., Wattjes, M. P., Scheltens, P., & Fox, N. C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.003 · Cited by 96
Self-citationGhidoni, R., Stoppani, E., Rossi, G., Piccoli, E., Albertini, V., Paterlini, A., Glionna, M., Pegoiani, E., Agnati, L. F., Fenoglio, C., et al. (2011) · Neurodegenerative Diseases · doi:10.1159/000333132 · Cited by 96
Hormone Replacement Therapy and Risk for Neurodegenerative Diseases
Dye, R. V., Miller, K. J., Singer, E. J., & Levine, A. J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/258454 · Cited by 99
Advances in neuroimaging in frontotemporal dementia
Gordón, E., Rohrer, J. D., & Fox, N. C. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13656 · Cited by 104
Self-citationImportance of Functional Loss of FUS in FTLD/ALS
Ishigaki, S., & Sobue, G. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00044 · Cited by 97
Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT
Morgan, S., Kemp, P. M., Booij, J., Costa, D. C., Padayachee, S., Lee, L., Barber, C., Carter, J., & Walker, Z. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302577 · Cited by 94
Pan, P. L., Song, W., Yang, J., Huang, R., Chen, K., Gong, Q. Y., Zhong, J. G., Shi, H. C., & Shang, H. F. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000338176 · Cited by 90
Coupland, K., Kim, W. S., Halliday, G. M., Hallupp, M., Dobson‐Stone, C., & Kwok, J. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157924 · Cited by 91
Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers
Meeter, L. H. H., Patzke, H., Loewen, G., Dopper, E. G. P., Pijnenburg, Y. A. L., van Minkelen, R., & van Swieten, J. C. (2016) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000447738 · Cited by 87
Self-citationde Souza, L. C., Marie Chupin, A., Bertoux, M., Lehéricy, S., Dubois, B., Lamari, F., Ber, I. L., Bottlaender, M., Olivier Colliot, A., & Sarazin, M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122293 · Cited by 91
Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): A misdiagnosed disease entity
Sundal, C., Lash, J., Aasly, J. O., Øygarden, S., Roeber, S., Kretzschman, H., Garbern, J. Y., Tselis, A. C., Rademakers, R., Dickson, D. W., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.10.006 · Cited by 87
Individual differences in socioemotional sensitivity are an index of salience network function
Toller, G., Brown, J. A., Sollberger, M. A., Shdo, S. M., Bouvet, L., Sukhanov, P., Seeley, W. W., Miller, B. L., & Rankin, K. P. (2018) · Cortex · doi:10.1016/j.cortex.2018.02.012 · Cited by 90
Conlon, E. G., Fagegaltier, D., Agius, P., Davis‐Porada, J., Gregory, J. A., Hubbard, I., Kang, K., Kim, D., Phatnani, H. P., Kwan, J. Y., et al. (2018) · eLife · doi:10.7554/elife.37754 · Cited by 86
Bertoux, M., Volle, E., Funkiewiez, A., de Souza, L. C., Leclercq, D., & Dubois, B. (2012) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617712001300 · Cited by 99
CYLD is a causative gene for frontotemporal dementia – amyotrophic lateral sclerosis
Dobson‐Stone, C., Hallupp, M., Shahheydari, H., Ragagnin, A., Chatterton, Z., Carew‐Jones, F., Shepherd, C. E., Stefen, H., Parić, E., Fath, T., et al. (2020) · Brain · doi:10.1093/brain/awaa039 · Cited by 86
Bron, E. E., Smits, M., Papma, J. M., Steketee, R. M. E., Meijboom, R., de Groot, M., van Swieten, J. C., Niessen, W. J., & Klein, S. (2017) · European Radiology · doi:10.1007/s00330-016-4691-x · Cited by 84
pySuStaIn: A Python implementation of the Subtype and Stage Inference algorithm
Aksman, L., Wijeratne, P. A., Oxtoby, N. P., Eshaghi, A., Shand, C., Altmann, A., Alexander, D. C., & Young, A. L. (2021) · SoftwareX · doi:10.1016/j.softx.2021.100811 · Cited by 91
Tau and MAPT genetics in tauopathies and synucleinopathies
Léveillé, E., Ross, O. A., & Gan‐Or, Z. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.09.008 · Cited by 87
The Role of Osteopontin in Neurodegenerative Diseases
Carecchio, M., & Comi, C. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-102151 · Cited by 79
Crespi, C., Cerami, C., Dodich, A., Canessa, N., Arpone, M., Iannaccone, S., Corbo, M., Lunetta, C., Scola, E., Falini, A., et al. (2014) · Cortex · doi:10.1016/j.cortex.2014.01.002 · Cited by 88
Psychosis in Frontotemporal Dementia
Shinagawa, S., Nakajima, S., Plitman, E., Graff‐Guerrero, A., Mimura, M., Nakayama, K., & Miller, B. L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140312 · Cited by 84
RNA-binding proteins in neurological diseases
Zhou, H.-L., Mangelsdorf, M., Liu, J., Zhu, L., & Wu, J. Y. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4647-9 · Cited by 82
Structural brain imaging in frontotemporal dementia
Rohrer, J. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.014 · Cited by 86
Self-citationIdentification of Conserved Proteomic Networks in Neurodegenerative Dementia
Swarup, V., Chang, T. S., Duong, D. M., Dammer, E. B., Dai, J., Lah, J. J., Johnson, E. C. B., Seyfried, N. T., Levey, A. I., & Geschwind, D. H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107807 · Cited by 78
Identification of conserved proteomic networks in neurodegenerative dementia
Swarup, V., Chang, T. S., Duong, D. M., Dammer, E. B., Lah, J. J., Johnson, E. E. C. B., Seyfried, N. T., Levey, A. I., & Geschwind, D. H. (2019) · doi:10.1101/825802 · Cited by 78
Proudfoot, M. J., Gutowski, N. J., Edbauer, D., Hilton, D. A., Stephens, M., Rankin, J., & Mackenzie, I. R. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1245-7 · Cited by 79
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia
Borroni, B., Benussi, A., Archetti, S., Galimberti, D., Parnetti, L., Nacmias, B., Sorbi, S., Scarpini, E., & Padovani, A. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.971812 · Cited by 77
Harciarek, M., & Cosentino, S. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.763340 · Cited by 77
Thomas, M., Alegre‐Abarrategui, J., & Wade‐Martins, R. (2013) · Brain · doi:10.1093/brain/awt030 · Cited by 75
Quantitative Analysis of Heterogeneity in Academic Achievement of Children With Autism
Chen, L., Abrams, D. A., Rosenberg‐Lee, M., Iuculano, T., Wakeman, H. N., Prathap, S., Chen, T., & Menon, V. (2018) · Clinical Psychological Science · doi:10.1177/2167702618809353 · Cited by 83
Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies
Young, A. L., Vogel, J. W., Robinson, J. L., McMillan, C. T., Ossenkoppele, R., Wolk, D. A., Irwin, D. J., Elman, L. B., Grossman, M., Lee, V. M. ‐., et al. (2023) · Brain · doi:10.1093/brain/awad145 · Cited by 84
ALS and frontotemporal dysfunction: a review
Achi, E. Y., & Rudnicki, S. A. (2012) · Neurology Research International · doi:10.1155/2012/806306 · Cited by 74
Younes, K., & Miller, B. L. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.006 · Cited by 76
Impaired protein degradation in FTLD and related disorders
Götzl, J. K., Lang, C. M., Haass, C., & Capell, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.008 · Cited by 75
Neural correlates of empathic impairment in the behavioral variant of frontotemporal dementia
Cerami, C., Dodich, A., Canessa, N., Crespi, C., Marcone, A., Cortese, F., Chierchia, G., Scola, E., Falini, A., & Cappa, S. F. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.01.005 · Cited by 73
Lemos, R., Duro, D., Simões, M. R., & Santana, I. J. (2014) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acu031 · Cited by 79
Metadata
- Authors
- Seelaar, H., Rohrer, J. D., Pijnenburg, Y. A. L., Fox, N. C., & van Swieten, J. C.
- Affiliations
- Erasmus MC (NL)
- National Hospital for Neurology and Neurosurgery (GB)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2010-10-22
- Volume
- 82
- Issue
- 5
- Pages
- 476-486
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2102932082
- Cited by
- 609
- References
- 222
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 39 · 2023: 23 · 2022: 35 · 2021: 33 · 2020: 44 · 2019: 42 · 2018: 34 · 2017: 31 · 2016: 49 · 2015: 41 · 2014: 45 · 2013: 65 · 2012: 54
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion, other-oa)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Alzheimer's Research Trust
- National Institute for Health and Care Research (NF-SI-0508-10123)
- Hersenstichting
- Stichting Dioraphte
- Medical Research Council
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- frontotemporal dementia, frontotemporal lobar degeneration, semantic dementia, progressive nonfluent aphasia, tauopathy, TDP-43, FUS, progranulin, tau protein, VCP, CHMP2B, amyotrophic lateral sclerosis, neuroimaging, brain atrophy, neuropsychological assessment, disease progression, early diagnosis, genetic heterogeneity
- MeSH terms
- Progranulins, Brain, Cognition, Humans, Magnetic Resonance Imaging, Risk Factors, Social Perception, Biomarkers, tau Proteins, Intercellular Signaling Peptides and Proteins, Executive Function, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
